Initiative for Health Education, Research, and Awareness for PMS and PMDD (iHera)

General Overview

iHera is a collaborative initiative dedicated to evaluating the impact of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) on students and academics across the EUniWell Alliance. By examining the prevalence and effects of premenstrual symptoms and promoting greater understanding and empathy, the project aims to create healthier and more inclusive academic environments. Harnessing the expertise of EUniWell medical students and guidance from specialists at partner universities, iHera will improve awareness and knowledge of PMS and PMDD through targeted education, support, and research.

Purpose and Significance

Despite significant research, awareness and understanding of PMS and PMDD remain insufficient, and many individuals affected by these conditions do not seek medical help due to stigma and lack of information. iHera seeks to change this by increasing awareness, fostering more supportive attitudes, and addressing biases within the academic community.

The project directly supports EUniWell's mission of enhancing health and well-being by focusing on an underrepresented yet impactful issue. By raising awareness and providing tailored support, iHera aims to improve the mental and physical well-being of students and staff members across all EUniWell universities. This initiative also leverages the collaborative potential of the EUniWell Alliance to deliver impactful, evidence-based interventions that benefit both individuals living with PMS and PMDD and the wider academic community.

Implementation Method and Timeline

The project will be implemented in three phases:

Phase One (Jan–Feb 2025):

  • Host an online conference featuring experts from partner universities and organisations to assess current awareness levels.
  • Conduct initial surveys to evaluate participants' knowledge and motivations.
  • Use detailed questionnaires to categorise participants by symptom severity.

Phase Two (Mar–Jul 2025):

  • Deliver tailored activities based on initial assessments:
    • Severe symptoms: Weekly consultations with healthcare professionals.
    • Moderate symptoms: Biweekly group sessions and workshops.
    • Mild symptoms: Monthly information sessions.
    • No symptoms: Focus groups to explore experiences and challenge biases.

Phase Three (Aug–Nov 2025):

  • Analyse data and gather participant feedback.
  • Organise a two-day hybrid symposium at Semmelweis University featuring participant insights and expert lectures.
  • Develop and disseminate a series of educational videos to ensure lasting impact and extend the project's reach.

Expected Outcomes

iHera aims to:

  1. Increase awareness of PMS and PMDD symptoms, impacts, and management strategies among both affected and unaffected individuals.

  2. Address external and internalised biases related to PMS and PMDD, fostering a more empathetic and supportive academic culture.

  3. Provide tailored solutions to support individuals based on the severity of their symptoms.

  4. Produce educational videos capturing participant experiences and project outcomes, extending the initiative's impact beyond its initial participants.

By achieving these goals, iHera will contribute to creating more equitable, understanding, and health-focused university environments across the EUniWell Alliance.

Contact:

Pana Djamtorki, Semmelweis University